bood pressure medication and stethoscope

Accuretic Recall

On March 21, 2022 Pfizer announced a voluntary recall of several lots of its blood pressure medication Accuretic along with two generic versions of the drug - quinapril and hydrochlorothiazide and quinapril HCI/hydrochlorothiazide. The Accuretic recall was initiated after unsafe levels of a nitrosamine, N-nitroso-quinapril, were detected in the medications. Long term exposure to levels of nitrosamines above the FDA’s Acceptable Daily Intake level is linked to cancer. The nitrosamine N-nitrosodimethylamine (NDMA) was previously detected in dangerously highly levels in Zantac and Valsartan, which ultimately led to recalls of both medications.

The Accuretic recall covers six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of quinapril HCI/hydrochlorothiazide tablets. The recalled Accuretic and quinapril products were distributed in the US from November 2019 to March 2022.

Full information on the lots recalled can be found below.

Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 10/12.5 mg
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/12.5 mg
Accuretic™ (quinapril HCl/hydrochlorothiazide) tablets, 20/25 mg

NDC

Lot Number

Expiration Date

Strength

Configuration/Count

0071-3112-23

FG5379

08/2024

10/12.5 mg

1 x 90 count bottle

0071-0222-23

EA6686

04/2022

10/12.5 mg

1 x 90 count bottle

0071-5212-23

FG5381

08/2024

20/12.5 mg

1 x 90 count bottle

0071-0220-23

EA6665

04/2022

20/12.5 mg

1 x 90 count bottle

0071-0220-23

CN0640

04/2022

20/12.5 mg

1 x 90 count bottle

0071-0223-23

ET6974

02/2023

20/25 mg

1 x 90 count bottle

quinapril and hydrochlorothiazide tablets, 20/25 mg
quinapril HCl/hydrochlorothiazide tablets, 20/12.5 mg
quinapril HCl/hydrochlorothiazide tablets, 20/25 mg

NDC

Lot Number

Expiration Date

Strength

Configuration/Count

59762-5225-9

FE3714

02/2023

20/25 mg

1 x 90 count bottle

59762-0220-1

DN6931

03/2023

20/12.5 mg

1 x 90 count bottle

59762-0220-1

ED3904

03/2023

20/12.5 mg

1 x 90 count bottle

59762-0220-1

ED3905

03/2023

20/12.5 mg

1 x 90 count bottle

59762-0223-1

DP3414

02/2023

20/25 mg

1 x 90 count bottle

GoldenbergLaw is representing hundreds of individuals who have been diagnosed with cancer due to nitrosamine contamination of medications. Our Accuretic recall attorneys have over 35 years of experience litigating defective drug claims and helping victims recover the compensation they deserve.

If you or a loved one has taken Accuretic or quinapril and received a recall letter or been diagnosed with cancer, contact our Minneapolis cancer attorneys today for a free consultation.

Categories

We Truly Care

The GoldenbergLaw Difference
  • Kindness Is Strength.

    With us, you matter most. This team spends the time to ensure clients like you get to rest and leave the sleepless nights to us.

  • Accountability Is Bravery.

    We live and breathe what we do, and we don't stop until the responsible party is held liable.

  • Leadership Is Trust.

    Our firm has been trusted to lead roles within some of the nation's largest litigations.

  • Knowledge Is Power.

    Our firm is focused on the science of the case and applying it to helping our clients recover.

Contact Us

We Focus On What You Need
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.